These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 21771823)
1. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K; Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823 [TBL] [Abstract][Full Text] [Related]
2. The European CRT Survey: 1 year (9-15 months) follow-up results. Bogale N; Priori S; Cleland JG; Brugada J; Linde C; Auricchio A; van Veldhuisen DJ; Limbourg T; Gitt A; Gras D; Stellbrink C; Gasparini M; Metra M; Derumeaux G; Gadler F; Buga L; Dickstein K; Eur J Heart Fail; 2012 Jan; 14(1):61-73. PubMed ID: 22179034 [TBL] [Abstract][Full Text] [Related]
3. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume. Bogale N; Priori S; Gitt A; Alings M; Linde C; Dickstein K; Europace; 2011 Oct; 13(10):1445-53. PubMed ID: 21712274 [TBL] [Abstract][Full Text] [Related]
4. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy. Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892 [TBL] [Abstract][Full Text] [Related]
5. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction). Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC; Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure. Davis DR; Krahn AD; Tang AS; Lemery R; Green MS; Gollob M; Yee R; Skanes AC; Klein GJ; Birnie DH Can J Cardiol; 2005 Apr; 21(5):413-7. PubMed ID: 15861258 [TBL] [Abstract][Full Text] [Related]
8. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure. Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283 [TBL] [Abstract][Full Text] [Related]
9. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy. Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD; Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574 [TBL] [Abstract][Full Text] [Related]
10. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker. Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L; Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry). Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A; Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388 [TBL] [Abstract][Full Text] [Related]
12. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. Pires LA; Abraham WT; Young JB; Johnson KM; Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543 [TBL] [Abstract][Full Text] [Related]
13. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD; Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974 [TBL] [Abstract][Full Text] [Related]
14. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE). Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796 [TBL] [Abstract][Full Text] [Related]
15. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C; J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193 [TBL] [Abstract][Full Text] [Related]
16. Effect of cardiac resynchronization therapy-defibrillator implantation on health status in patients with mild versus moderate symptoms of heart failure. Versteeg H; van den Broek KC; Theuns DA; Mommersteeg PM; Alings M; van der Voort PH; Jordaens L; Pedersen SS Am J Cardiol; 2011 Oct; 108(8):1155-9. PubMed ID: 21821227 [TBL] [Abstract][Full Text] [Related]
17. Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate. Duray GZ; Israel CW; Pajitnev D; Hohnloser SH Europace; 2008 Jan; 10(1):48-52. PubMed ID: 18077483 [TBL] [Abstract][Full Text] [Related]
18. Implantation of left ventricular epicardial leads in cardiosurgical patients with impaired cardiac function--a worthwhile procedure in concomitant surgical interventions? Mellert F; Schneider C; Esmailzadeh B; Balta O; Haushofer M; Schiller W; Preusse CJ; Welz A Thorac Cardiovasc Surg; 2012 Feb; 60(1):64-9. PubMed ID: 21425053 [TBL] [Abstract][Full Text] [Related]
19. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867 [TBL] [Abstract][Full Text] [Related]
20. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing. Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]